Log In
BCIQ
Print this Print this
 

Proprotein convertase subtilisin/kexin type 9 (PCSK9)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Proprotein convertase subtilisin/kexin type 9 (PCSK9)

BCIQ
Print ChartPrint this
Marketed, 2 Phase III, 1 Phase II, 2 Phase II, 2 Phase I, 6 Preclinical, 3
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIMarketed
Cardiovascular

-

-

2

-

-

Endocrine / Metabolic

3

6

2

1

2




 Products Targeting Proprotein convertase subtilisin/kexin type 9 (PCSK9)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$205.0M

$25.0M

$180.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today